is tirzepatide coming off the market FDA says the Zepbound shortage over. That's rattling the weight loss industry FDA says this weight loss

Conditions That Call For Closer Monitoring While On Semaglutide Atrial fibrillation or other clinically significant arrhythmias: monitor rhythm and symptoms

For Coaches Managing GLP-1 Clients If you coach semaglutide clients and need a cleaner way to manage weekly check-ins, adherence, side-effect notes, nutrition, training, and client communication, PhysiqueOS now has a dedicated coach-side GLP-1 workflow.

By enhancing your bodys sensitivity to insulin, semaglutide helps reduce the production and accumulation of triglycerides

Tirzepatide has been shown to support greater average weight loss than placebo, with some participants losing a significant amount of their starting weight

Tirzepatide is the first FDA-approved medication for obesity that activates both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor

Increasing water and fiber intake helps manage this